Formulation patent

關於「Formulation patent」標籤，搜尋引擎有相關的訊息討論：

Patents: dosage and formulation patents - Bird & BirdThe High Court has held that a drug formulation patent was invalid but a patent relating to dosage of the drug was valid and infringed. Background. A patent may  ... | G‑VII, 5.2 Formulation of the objective technical problem ...2021年3月1日 · European Patent Convention - This area contains legal texts from the EPO, including the European Patent Convention, Ancillary regulations to ...An overview of patents on therapeutic monoclonal antibodies in ...2020年4月19日 · As patents on many high-selling biological medicines are expiring, non-innovator versions, such as biosimilars ... Also, biosimilars can be protected by filing new patents and these mainly pertain to new formulations. ... Boca Raton (FL): Taylor & Francis Group; 2016. ... Taylor and Francis Group Twitter page.An overview of patents on therapeutic monoclonal ... - NCBI - NIH2020年4月19日 · An overview of patents on therapeutic monoclonal antibodies in Europe: are they a ... Patenting a new formulation may also be possible. ... Boca Raton (FL): Taylor & Francis Group; 2016. ... Twitter · Share on Google Plus ... tw | twGeneral information concerning patents | USPTOThe preparation of an application for patent and the conducting of the proceedings in the United States Patent and Trademark Office to obtain the patent is an ... twConsiderations for formulation and combination patents in Europe ...2021年5月17日 · In this article, we consider patent applications to new drug formulations and combinations. Where a substance or composition is already known ... | Frequently Asked Questions on Patents and Exclusivity | FDA2020年2月5日 · Drug patents and exclusivity: FDA answers the most frequently asked ... to change the formulation, to add a new indication or other condition of ... twUS10344765B2 - Stable liquid formulation of AMG ... - Google PatentsA liquid formulation comprising a peptide agonist of the calcium sensing ... Publication of US10344765B2 publication Critical patent/US10344765B2/en ... Active; 2014-06-27 TW TW103122433A patent/TWI635874B/en active; 2014-06- 27 CR ... | Impax Labs., Inc. v. Actavis Labs. FL, Inc. | Robins Kaplan LLP ...2018年5月1日 · Impax sued Actavis alleging patent infringement based on the filing of ... the beads in its formulation containing tartaric acid, a carboxylic acid, ...Recent Patents Concerning the use of Nanotechnology-based ...2020年1月10日 · Journal Name: Recent Patents on Drug Delivery & Formulation ... Keywords: Nanotechnology-based delivery systems, patents, penetration ...